Norman Eansor
Chairman at MARKER THERAPEUTICS, INC.
Net worth: 16 124 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Juan Vera | M | 44 | 6 years | |
| Marc Casper | M | 56 | 23 years | |
| Kim Kelderman | M | 57 | 6 years | |
| James Hippel | M | 53 |
CyVek, Inc.
 CyVek, Inc. BiotechnologyHealth Technology CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT. | 7 years |
| Shane Bohnen | M | 49 | 5 years | |
| John Wilson | M | 64 | - | |
| Jeffrey Scott Liter | M | 67 |
B-MoGen Biotechnologies, Inc.
 B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology B-MoGen Biotechnologies, Inc. provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing. It offers custom vector generation services that include multi-gene expression vectors that are delivered via the proven sleeping beauty transposon system; and custom gene targeting vectors. The company was founded by David A. Largaespada and Branden S. Moriarity in 2015 and is headquartered in Minneapolis, MN. | - |
| Gerald Garrett | M | 59 | 5 years | |
| Katharine Knobil | M | 60 | 3 years | |
| Alpna Seth | M | 60 | 7 years | |
| Branden S. Moriarity | M | - |
B-MoGen Biotechnologies, Inc.
B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology B-MoGen Biotechnologies, Inc. provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing. It offers custom vector generation services that include multi-gene expression vectors that are delivered via the proven sleeping beauty transposon system; and custom gene targeting vectors. The company was founded by David A. Largaespada and Branden S. Moriarity in 2015 and is headquartered in Minneapolis, MN. | 9 years |
| C. Harris | M | 67 | 12 years | |
| Rupert Vessey | M | 59 | 5 years | |
| Daniel P. Shine | M | - | 26 years | |
| Stephen Williamson | M | 57 | 23 years | |
| David A. Largaespada | M | - |
B-MoGen Biotechnologies, Inc.
B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology B-MoGen Biotechnologies, Inc. provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing. It offers custom vector generation services that include multi-gene expression vectors that are delivered via the proven sleeping beauty transposon system; and custom gene targeting vectors. The company was founded by David A. Largaespada and Branden S. Moriarity in 2015 and is headquartered in Minneapolis, MN. | 9 years |
| Scott Sperling | M | 66 | 18 years | |
| Brenda Furlow | F | 66 |
CyVek, Inc.
CyVek, Inc. BiotechnologyHealth Technology CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT. | - |
| Joseph Keegan | M | 71 | 7 years | |
| Steven Elms | M | 60 | 5 years | |
| Nelson Chai | M | 58 | 14 years | |
| Julie Bushman | F | 63 | 4 years | |
| Enrique Alan Posner | M | 60 |
CyVek, Inc.
CyVek, Inc. BiotechnologyHealth Technology CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT. | 14 years |
| Cory Stevenson | M | - | 16 years | |
| Qi Cheng | F | - | 3 years | |
| Gil Mor | M | - |
CyVek, Inc.
CyVek, Inc. BiotechnologyHealth Technology CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT. | - |
| Edmund Cheung | M | - | 3 years | |
| Gianluca Pettiti | M | 45 | 18 years | |
| William Geist | M | 55 | 2 years | |
| Nadia Agopyan | M | 62 | 5 years | |
| Erwin A. Kelen | M | 89 |
B-MoGen Biotechnologies, Inc.
B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology B-MoGen Biotechnologies, Inc. provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing. It offers custom vector generation services that include multi-gene expression vectors that are delivered via the proven sleeping beauty transposon system; and custom gene targeting vectors. The company was founded by David A. Largaespada and Branden S. Moriarity in 2015 and is headquartered in Minneapolis, MN. | - |
| Frederick Lowery | M | 53 | 19 years | |
| Tsvetelina Pencheva Hoang | M | 51 | 6 years | |
| Kevin Rakin | M | 63 |
CyVek, Inc.
CyVek, Inc. BiotechnologyHealth Technology CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT. | 12 years |
| James G. Farrell | M | 57 | 19 years | |
| Mike Rusinko | M | - |
B-MoGen Biotechnologies, Inc.
B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology B-MoGen Biotechnologies, Inc. provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing. It offers custom vector generation services that include multi-gene expression vectors that are delivered via the proven sleeping beauty transposon system; and custom gene targeting vectors. The company was founded by David A. Largaespada and Branden S. Moriarity in 2015 and is headquartered in Minneapolis, MN. | - |
| Mike Shafer | M | - | 15 years | |
| Elizabeth Donnelly | F | - | 9 years | |
| Kenneth Ray Moseley | M | 67 | 6 years | |
| Tyler Jacks | M | 63 | 15 years | |
| Monic Stuart | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Glynn Wilson | M | 74 | 13 years | |
| Karen Padgett | F | 60 |
Novus Biologicals LLC
 Novus Biologicals LLC Pharmaceuticals: MajorHealth Technology Novus Biologicals LLC develops and markets antibodies for scientific researchers in government, university, and biotech labs worldwide. It provides primary antibodies, secondary antibodies, antibody packs, lysates, peptides and proteins, antibody pairs, kits, RNAi, slides, isotype controls, support products, and various research reagents. Novus products are used in various research areas, including apoptosis, autophagy, cancer, DNA repair, epigenetics, epitope tags, GPCR, hypoxia, lipid and metabolism, loading controls, neuroscience, stem cell markers, cellular markers, immunology, and protein turnover. The company was founded by Karen M. Padgett in 1996 and is headquartered Littleton, CO. | 23 years |
| Richard F. Syron | M | 80 | 6 years | |
| Marijn Dekkers | M | 65 | 9 years | |
| Michael Loiacono | M | 58 | 7 years | |
| Gregory Sargen | M | 58 | 17 years | |
| Neda Safarzadeh | F | - | - | |
| William Parfet | M | 77 | 3 years | |
| Peter Hoang | M | 52 | 6 years | |
| Mark Reddish | M | 69 | 7 years | |
| Jim Manzi | M | 72 | 23 years | |
| Frederick Wasserman | M | 69 | 6 years | |
| William Parrett | M | 78 | 10 years | |
| Eliot Lurier | M | 66 | - | |
| Marc Tremblay | M | 57 | 9 years | |
| Peter G. Tombros | M | 81 | 16 years | |
| Roger C. Lucas | M | 81 | 32 years | |
| Pradeep Ittycheria | M | 47 | - | |
| David Laskow-Pooley | M | 69 | 8 years | |
| Claudio Russolo | M | - | - | |
| Drew Enamait | M | 50 | 1 years | |
| Susan Rice | F | 65 | 11 years | |
| Karen A. Kirkwood | F | - | 15 years | |
| Ann M. Leen | M | 47 | 2 years | |
| Mythili Koneru | M | 46 | 4 years | |
| Bryan Poltilove | M | - | 11 years | |
| Tom Lynch | M | 69 | 13 years | |
| Sherry Grisewood | F | 71 | 5 years | |
| Michael Porter | M | 76 | 11 years | |
| John Leone | M | 77 | 2 years | |
| Salvatore Guccione | M | 61 | 9 years | |
| Lars Rebien Sørensen | M | 69 | 4 years | |
| Paul Meister | M | 71 | 9 years | |
| Howard V. O'Connell | M | 94 | 30 years | |
| Peter Wilver | M | 64 | 17 years | |
| Elaine S. Ullian | F | 76 | 19 years | |
| Judy Lewent | F | 75 | 13 years | |
| Karen Holbrook | M | 81 | 10 years | |
| Peter Manning | M | 85 | - | |
| Harold Wiens | M | 77 | 6 years | |
| Charles A. Dinarello | M | 81 | 13 years | |
| Kari E. Leetch | M | - | 4 years | |
| Guy Broadbent | M | 60 | - | |
| David Bespalko | M | 68 | 8 years | |
| Robert A. McCabe | M | 89 | - | |
| Watchara Weraporasu | M | 46 | 8 years | |
| Patrice Barnes | F | - | 9 years | |
| Paco Cifuentes | M | - | 4 years | |
| Nadia Altomare | F | 54 | 2 years | |
| Peter E. Hornstra | M | 64 | 20 years | |
| Ian Purdy | M | - | - | |
| David Malinas | M | 49 | 5 years | |
| Stephen G. Sheehan | M | 68 | - | |
| Alan Malus | M | 64 | 10 years | |
| Ron O'Brien | M | - | - | |
| Fredric T. Walder | M | 67 | 18 years | |
| Alexander G. Stachtiaris | M | 59 | - | |
| Carsten Hellmann | M | 60 | - | |
| Sundiep Phanse | M | - | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Norman Eansor
- Personal Network
